A Phase 2, Multi-Center, Randomized, Double-Blind, Controlled Trial Evaluating the Safety and Efficacy of ENV-101 in Patients with Lung Fibrosis (WHISTLE-PF Trial)

Project Details

StatusActive
Effective start/end date2/09/24 → 30/09/27

Funding

  • PAREXEL International Pty. Ltd.: A$30,000.00